Search research articles
Contact Us
Filters
Showing results (61-70 of 148) with videos related to
Page
of 15
Sort By:
Schweizerische Medizinische Wochenschrift
|
November 1, 1980
[Ovarian carcinoma: new prognostic and therapeutic viewpoints]
A Goldhirsch, R Joss, R Greiner, et al.
Cancer Treatment Reviews
|
June 1, 1982
Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma
A Goldhirsch, R Joss, F Cavalli, et al.
Journal of Steroid Biochemistry
|
December 1, 1985
Hormono-chemotherapy in the treatment of advanced breast cancer
F Cavalli, A Goldhirsch, R Joss, et al.
Schweizerische Medizinische Wochenschrift
|
March 26, 1983
[High-dosage methylprednisolone as an antiemetic in cytostatic-induced vomiting]
R Joss, A Gervasi, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1990
Bioavailability of subcutaneous ifosfamide and feasibility of continuous outpatient application in cancer patients
T Cerny, A Küpfer, T Zeugin, et al.
European Journal of Clinical Pharmacology
|
January 1, 1983
Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy
R A Joss, R L Galeazzi, K W Brunner
Schweizerische Medizinische Wochenschrift
|
August 26, 1989
[Urinary bioavailability of sodium-2-mercaptoethanesulfonate (Uromitexan) following intravenous, subcutaneous and continuous subcutaneous administration]
B Roth, T Cerny, K W Brunner, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 27, 1980
[Vindesine, a new cytostatic agent from the vinca alkaloids]
A Goldhirsch, R Joss, R W Sonntag, et al.
Cancer Treatment Reviews
|
September 1, 1986
New drugs in small-cell lung cancer
R A Joss, F Cavalli, A Goldhirsch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Phase II study of continuous subcutaneous interferon-alfa combined with cisplatin in advanced malignant melanoma
J Richner, R A Joss, A Goldhirsch, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 148) with videos related to
Sort By:
Page
of 15
Schweizerische Medizinische Wochenschrift
|
November 1, 1980
[Ovarian carcinoma: new prognostic and therapeutic viewpoints]
A Goldhirsch, R Joss, R Greiner, et al.
Cancer Treatment Reviews
|
June 1, 1982
Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma
A Goldhirsch, R Joss, F Cavalli, et al.
Journal of Steroid Biochemistry
|
December 1, 1985
Hormono-chemotherapy in the treatment of advanced breast cancer
F Cavalli, A Goldhirsch, R Joss, et al.
Schweizerische Medizinische Wochenschrift
|
March 26, 1983
[High-dosage methylprednisolone as an antiemetic in cytostatic-induced vomiting]
R Joss, A Gervasi, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1990
Bioavailability of subcutaneous ifosfamide and feasibility of continuous outpatient application in cancer patients
T Cerny, A Küpfer, T Zeugin, et al.
European Journal of Clinical Pharmacology
|
January 1, 1983
Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy
R A Joss, R L Galeazzi, K W Brunner
Schweizerische Medizinische Wochenschrift
|
August 26, 1989
[Urinary bioavailability of sodium-2-mercaptoethanesulfonate (Uromitexan) following intravenous, subcutaneous and continuous subcutaneous administration]
B Roth, T Cerny, K W Brunner, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 27, 1980
[Vindesine, a new cytostatic agent from the vinca alkaloids]
A Goldhirsch, R Joss, R W Sonntag, et al.
Cancer Treatment Reviews
|
September 1, 1986
New drugs in small-cell lung cancer
R A Joss, F Cavalli, A Goldhirsch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Phase II study of continuous subcutaneous interferon-alfa combined with cisplatin in advanced malignant melanoma
J Richner, R A Joss, A Goldhirsch, et al.
Page
of 15